NOT FOR RELEASE OR DISTRIBUTION IN THE USA, CANADA, AUSTRALIA OR JAPAN.
 

SHOP APOTHEKE EUROPE: Strong sales growth also in May reaffirms guidance.

The company benefits from general shift to online OTC purchases.

• Number of active customers increased to 2.2. million by the end of May.
• Strong business development continued in May.
• OTC business remains a major growth driver of the market.

Venlo/Cologne, 21 June 2017. Approximately eight months after the successful IPO, SHOP APOTHEKE EUROPE N.V., the leading European OTC online pharmacy, has further increased the number of active customers to 2.2 million. As a result of new customer growth, sales growth in Germany and in the international markets has accelerated since the IPO. The provisional month-end May again shows an increase at the upper end of the forecast.

So SHOP APOTHEKE EUROPE the fastest growing OTC online pharmacy in Europe. The company is already active in Germany, Austria, the Netherlands, Belgium, France, Italy and Spain. Thereby it has a unique international presence in the relevant European markets. The shops in the individual countries have been tailored to the different local needs and wishes of the customers, also containing country-specific assortments and products.

Not only for customers, but also for industry insiders, SHOP APOTHEKE EUROPE is the clear number one among the online pharmacies. The company recently became the winner in the online pharmacy survey of the 14th SEMPORA Market Study, which takes the independent assessment by pharmaceutical companies into account. SHOP APOTHEKE EUROPE reached this top position for the fifth time in a row.

"Our above-average growth combined with the high level of satisfaction and loyalty of our customers show that we are internationally leading the market of OTC and Beauty and Personal Care Products. We benefit strongly from the accelerated shift from offline to online purchases", concludes Michael Köhler, CEO of SHOP APOTHEKE EUROPE.
 

ABOUT SHOP APOTHEKE EUROPE.

SHOP APOTHEKE EUROPE is Continental Europe's leading online OTC pharmacy with a portfolio that focuses on OTC medication and pharmacy-related beauty and care products (BPC). The Company operates online pharmacies in Germany, Austria, France, Belgium, Italy, Spain and the Netherlands. In Germany, the TÜV-certified shop-apotheke.com is the market leader in terms of traffic. SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original products to 2.2 million active customers (May 2017) quickly and at attractive prices. In addition, SHOP APOTHEKE EUROPE provides comprehensive and consistent pharmaceutical services.

SHOP APOTHEKE EUROPE generated sales of around EUR 64 million in the first quarter of 2017 and a growth of + 56% compared to the same quarter last year. Headquartered in Venlo (the Netherlands), SHOP APOTHEKE EUROPE also has offices in Cologne, Düsseldorf, Paris and Tongeren, Belgium. The online pharmacy has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 13 October 2016.

MEDIA CONTACTS.

Trade and public media:
Sven Schirmer
Mobil: +49 152 28 50 63 61
E-Mail: presse@shop-apotheke.com

Financial media:
Thomas Schnorrenberg
Mobil: +49 151 46 53 13 17
E-Mail: presse@shop-apotheke.com

Investor Relations:
Dr. Ulrich Wandel
Telefphone: +31 77 850 6117
E-Mail: ulrich.wandel@shop-apotheke.com

DISCLAIMER.

This announcement does not constitute a public offer or an offer to subscribe to any securities in any jurisdiction. The offer was made exclusively on the basis of the company's securities prospectus that had been published in connection with the offer. The shares have already been sold.

This announcement contains forward-looking statements that relate to the future course of business and future financial performance, as well as future transactions or developments concerning SHOP APOTHEKE EUROPE. The bases of these statements are current expectations and assumptions of SHOP APOTHEKE EUROPE's management, of which a large number are outside SHOPE APOTHEKE EUROPE's sphere of influence. These statements are therefore subject to a variety of risks and uncertainties. If such risks and uncertainties occur, or if the underlying expectations do not materialize or the assumptions made are not correct, the actual events, both positive and negative, may differ materially from those events contained in the forward-looking statements. SHOP APOTHEKE EUROPE assumes no obligation to update these forward-looking statements or to correct them in the event of occurrences or developments other than those anticipated. Such updates or corrections are not intended.